Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Drug Discovery Process Services In Europe
11 services found
Manufactured by:Molecule One sp. z o.o. based inWarszawa (Polska), POLAND
When all components of the M1 platform are deployed, along with a proprietary dataset, your entire discovery pipeline benefits. You may generate millions of compounds with high estimated synthetic accessibility, reduce reaction failure rates at the bench or automate your synthesis workflows. That enables your team to focus on more crucial discovery tasks. We can help you build a pipeline where ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
The drug-discovery process is a trial-and-error run and time-consuming. Currently, using in silico tools to find a molecule that binds to the target protein has made computational chemistry a valuable tool in drug ...
by:PharmAI GmbH based inDresden, GERMANY
High-Throughput-Screening (HTS) is the experimental method predominantly used today in the drug discovery process. In this process, typically 50.000 to 200.000 compounds, in small containers, are screened and observed for reactions between the compounds and the ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug ...
by:Oncodesign based inDijon, FRANCE
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, Oncodesign ...
by:Oncodesign based inDijon, FRANCE
DRIVE-IDDS, an integrated drug discovery solution: a complete continuum from target to clinical candidate. ...
by:PharmAI GmbH based inDresden, GERMANY
pharmAI's innovative solution, which is based on analysing the binding sites, decreases the screening space dramatically. pharmAIs algorithms provide the drug developers with predictions of one or multiple constrained compound space(s) that can easily be passed on to compound library manufacturers (for cherry ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro has a vast range of tools that help accelerate your drug discovery and development process. Our technology platforms support key decision-making in: Early discovery and screening. Candidate selection. First-in-human translation and early development. Late stage, multi-center determination of ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions' Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Compared with normal cells, tumor cells have undergone a series of genetic and epigenetic alterations that, in general, underlie cancer development, progression, and drug resistance. Tumor-derived cell lines have served as important models to advance our understanding of oncogene function and therapeutic responses. Creative Bioarray provides human tumor cells sourced from a ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Creative Bioarray provides various in vitro ADME/PK services including high-throughput ADME screening, in vitro metabolism, in vitro permeability and transporter assays. ADME is short for "absorption, distribution, metabolism, and excretion". The four properties determine the drug level within a body, the drug exposure to tissues, and the metabolic process of a compound, which can help predict ...